-
1
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocar...
Veröffentlicht in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
VolltextArtikel -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Veröffentlicht in Nature medicine
VolltextArtikel -
20